{"id":"https://openalex.org/W1981303671","doi":"https://doi.org/10.1007/bf00685849","title":"Antitumor activity of FCE 26644 a new growth-factor complexing molecule","display_name":"Antitumor activity of FCE 26644 a new growth-factor complexing molecule","publication_year":1995,"publication_date":"1995-01-01","ids":{"openalex":"https://openalex.org/W1981303671","doi":"https://doi.org/10.1007/bf00685849","mag":"1981303671","pmid":"https://pubmed.ncbi.nlm.nih.gov/7781141"},"language":"en","primary_location":{"id":"doi:10.1007/bf00685849","doi":"https://doi.org/10.1007/bf00685849","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf00685849","pdf_url":null,"source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045284942","display_name":"Francesco Sola","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127540","display_name":"Nerviano Medical Sciences","ror":"https://ror.org/038mzt421","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210127540"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesco Sola","raw_affiliation_strings":["Pharmacia-Farmitalia Carlo Erba, R&D/Business Area Oncology-Oncology Laboratory, Nerviano/Milan, Italy","R&D/Business Area Oncology-Oncology Laboratory, Pharmacia-Farmitalia Carlo Erba, Research Center, Nerviano/Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacia-Farmitalia Carlo Erba, R&D/Business Area Oncology-Oncology Laboratory, Nerviano/Milan, Italy","institution_ids":[]},{"raw_affiliation_string":"R&D/Business Area Oncology-Oncology Laboratory, Pharmacia-Farmitalia Carlo Erba, Research Center, Nerviano/Milan, Italy","institution_ids":["https://openalex.org/I4210127540"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090067835","display_name":"Mariella Farao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127540","display_name":"Nerviano Medical Sciences","ror":"https://ror.org/038mzt421","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210127540"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Mariella Farao","raw_affiliation_strings":["R&D/Business Area Oncology-Oncology Laboratory, Pharmacia-Farmitalia Carlo Erba, Research Center, Via Giovanni XXIII, 23, I-20014, Nerviano/Milan, Italy","R&D/Business Area Oncology-Oncology Laboratory, Pharmacia-Farmitalia Carlo Erba, Research Center, Nerviano/Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R&D/Business Area Oncology-Oncology Laboratory, Pharmacia-Farmitalia Carlo Erba, Research Center, Via Giovanni XXIII, 23, I-20014, Nerviano/Milan, Italy","institution_ids":["https://openalex.org/I4210127540"]},{"raw_affiliation_string":"R&D/Business Area Oncology-Oncology Laboratory, Pharmacia-Farmitalia Carlo Erba, Research Center, Nerviano/Milan, Italy","institution_ids":["https://openalex.org/I4210127540"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083934929","display_name":"Enrico A. Pesenti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127540","display_name":"Nerviano Medical Sciences","ror":"https://ror.org/038mzt421","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210127540"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Enrico Pesenti","raw_affiliation_strings":["R&D/Business Area Oncology-Oncology Laboratory, Pharmacia-Farmitalia Carlo Erba, Research Center, Via Giovanni XXIII, 23, I-20014, Nerviano/Milan, Italy","R&D/Business Area Oncology-Oncology Laboratory, Pharmacia-Farmitalia Carlo Erba, Research Center, Nerviano/Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R&D/Business Area Oncology-Oncology Laboratory, Pharmacia-Farmitalia Carlo Erba, Research Center, Via Giovanni XXIII, 23, I-20014, Nerviano/Milan, Italy","institution_ids":["https://openalex.org/I4210127540"]},{"raw_affiliation_string":"R&D/Business Area Oncology-Oncology Laboratory, Pharmacia-Farmitalia Carlo Erba, Research Center, Nerviano/Milan, Italy","institution_ids":["https://openalex.org/I4210127540"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111935899","display_name":"Aurelio Marsiglio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127540","display_name":"Nerviano Medical Sciences","ror":"https://ror.org/038mzt421","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210127540"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Aurelio Marsiglio","raw_affiliation_strings":["R&D/Business Area Oncology-Oncology Laboratory, Pharmacia-Farmitalia Carlo Erba, Research Center, Via Giovanni XXIII, 23, I-20014, Nerviano/Milan, Italy","R&D/Business Area Oncology-Oncology Laboratory, Pharmacia-Farmitalia Carlo Erba, Research Center, Nerviano/Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R&D/Business Area Oncology-Oncology Laboratory, Pharmacia-Farmitalia Carlo Erba, Research Center, Via Giovanni XXIII, 23, I-20014, Nerviano/Milan, Italy","institution_ids":["https://openalex.org/I4210127540"]},{"raw_affiliation_string":"R&D/Business Area Oncology-Oncology Laboratory, Pharmacia-Farmitalia Carlo Erba, Research Center, Nerviano/Milan, Italy","institution_ids":["https://openalex.org/I4210127540"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022738573","display_name":"Nicola Mongelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127540","display_name":"Nerviano Medical Sciences","ror":"https://ror.org/038mzt421","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210127540"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Nicola Mongelli","raw_affiliation_strings":["R&D/Business Area Oncology-Oncology Laboratory, Pharmacia-Farmitalia Carlo Erba, Research Center, Via Giovanni XXIII, 23, I-20014, Nerviano/Milan, Italy","R&D/Business Area Oncology-Oncology Laboratory, Pharmacia-Farmitalia Carlo Erba, Research Center, Nerviano/Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R&D/Business Area Oncology-Oncology Laboratory, Pharmacia-Farmitalia Carlo Erba, Research Center, Via Giovanni XXIII, 23, I-20014, Nerviano/Milan, Italy","institution_ids":["https://openalex.org/I4210127540"]},{"raw_affiliation_string":"R&D/Business Area Oncology-Oncology Laboratory, Pharmacia-Farmitalia Carlo Erba, Research Center, Nerviano/Milan, Italy","institution_ids":["https://openalex.org/I4210127540"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045153764","display_name":"Maria Grandi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127540","display_name":"Nerviano Medical Sciences","ror":"https://ror.org/038mzt421","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210127540"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Grandi","raw_affiliation_strings":["R&D/Business Area Oncology-Oncology Laboratory, Pharmacia-Farmitalia Carlo Erba, Research Center, Via Giovanni XXIII, 23, I-20014, Nerviano/Milan, Italy","R&D/Business Area Oncology-Oncology Laboratory, Pharmacia-Farmitalia Carlo Erba, Research Center, Nerviano/Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R&D/Business Area Oncology-Oncology Laboratory, Pharmacia-Farmitalia Carlo Erba, Research Center, Via Giovanni XXIII, 23, I-20014, Nerviano/Milan, Italy","institution_ids":["https://openalex.org/I4210127540"]},{"raw_affiliation_string":"R&D/Business Area Oncology-Oncology Laboratory, Pharmacia-Farmitalia Carlo Erba, Research Center, Nerviano/Milan, Italy","institution_ids":["https://openalex.org/I4210127540"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210127540"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":0.7262,"has_fulltext":false,"cited_by_count":27,"citation_normalized_percentile":{"value":0.6543747,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"36","issue":"3","first_page":"217","last_page":"222"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.5903000235557556,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.5903000235557556,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":0.3215000033378601,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.054099999368190765,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.8569999933242798},{"id":"https://openalex.org/keywords/suramin","display_name":"suramin","score":0.8040000200271606},{"id":"https://openalex.org/keywords/basic-fibroblast-growth-factor","display_name":"basic fibroblast growth factor","score":0.953000009059906},{"id":"https://openalex.org/keywords/platelet-derived-growth-factor","display_name":"platelet-derived growth factor","score":0.8830000162124634},{"id":"https://openalex.org/keywords/interleukin-7","display_name":"IL-7","score":0.8899999856948853},{"id":"https://openalex.org/keywords/angiogenesis-inhibition","display_name":"angiogenesis inhibition","score":0.7570000290870667},{"id":"https://openalex.org/keywords/neovascularization","display_name":"neovascularization","score":0.8080000281333923},{"id":"https://openalex.org/keywords/chorioallantoic-membrane","display_name":"chorioallantoic membrane","score":0.9079999923706055},{"id":"https://openalex.org/keywords/fibrosarcoma","display_name":"fibrosarcoma","score":0.7870000004768372},{"id":"https://openalex.org/keywords/reticulum-cell-sarcoma","display_name":"reticulum cell sarcoma","score":0.9120000004768372},{"id":"https://openalex.org/keywords/cyclophosphamide-resistance","display_name":"cyclophosphamide resistance","score":0.8690000176429749}],"concepts":[{"id":"https://openalex.org/C2776182878","wikidata":"https://www.wikidata.org/wiki/Q425946","display_name":"Suramin","level":3,"score":0.7209317088127136},{"id":"https://openalex.org/C2776495794","wikidata":"https://www.wikidata.org/wiki/Q1362453","display_name":"Fibrosarcoma","level":2,"score":0.6752620935440063},{"id":"https://openalex.org/C97230052","wikidata":"https://www.wikidata.org/wiki/Q3854334","display_name":"Chorioallantoic membrane","level":3,"score":0.6354268193244934},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.603406548500061},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5442493557929993},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.49732235074043274},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.4922238886356354},{"id":"https://openalex.org/C180361614","wikidata":"https://www.wikidata.org/wiki/Q7202242","display_name":"Platelet-derived growth factor receptor","level":4,"score":0.4886975586414337},{"id":"https://openalex.org/C2777587049","wikidata":"https://www.wikidata.org/wiki/Q20969945","display_name":"Basic fibroblast growth factor","level":4,"score":0.48243746161460876},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.42336422204971313},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4232906401157379},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4035266935825348},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.38666054606437683},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34973204135894775},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.32543325424194336},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3215278387069702},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22255471348762512},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2088213562965393},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.10605689883232117},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004214","descriptor_name":"Distamycins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004214","descriptor_name":"Distamycins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005354","descriptor_name":"Fibrosarcoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008546","descriptor_name":"Melanoma, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008809","descriptor_name":"Mice, Inbred C3H","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008811","descriptor_name":"Mice, Inbred DBA","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013498","descriptor_name":"Suramin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D013498","descriptor_name":"Suramin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016222","descriptor_name":"Fibroblast Growth Factor 2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1007/bf00685849","doi":"https://doi.org/10.1007/bf00685849","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf00685849","pdf_url":null,"source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},{"id":"doi:10.1007/s002800050311","doi":"https://doi.org/10.1007/s002800050311","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s002800050311","pdf_url":null,"source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},{"id":"pmid:7781141","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7781141","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer chemotherapy and pharmacology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W1557228442","https://openalex.org/W1573420482","https://openalex.org/W1642177429","https://openalex.org/W1807482481","https://openalex.org/W1928466038","https://openalex.org/W1969328947","https://openalex.org/W1970514155","https://openalex.org/W1972580962","https://openalex.org/W1974491777","https://openalex.org/W1978957750","https://openalex.org/W1992401642","https://openalex.org/W2001046604","https://openalex.org/W2004684799","https://openalex.org/W2008808264","https://openalex.org/W2026151657","https://openalex.org/W2052897849","https://openalex.org/W2056854271","https://openalex.org/W2057409901","https://openalex.org/W2066423930","https://openalex.org/W2081439037","https://openalex.org/W2085904053","https://openalex.org/W2086497422","https://openalex.org/W2109499006","https://openalex.org/W2117066001","https://openalex.org/W2124825512","https://openalex.org/W2140353655","https://openalex.org/W2161562135","https://openalex.org/W2204115562","https://openalex.org/W2237040806","https://openalex.org/W2242063705","https://openalex.org/W2319962899","https://openalex.org/W2418752850","https://openalex.org/W4255042798"],"related_works":["https://openalex.org/W2027090478","https://openalex.org/W2081439037","https://openalex.org/W2160573566","https://openalex.org/W4205665440","https://openalex.org/W2034344470","https://openalex.org/W2074716300","https://openalex.org/W2401029002","https://openalex.org/W2093728648","https://openalex.org/W2242063705","https://openalex.org/W2402476409"],"abstract_inverted_index":null,"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}